EAM
AVNS

EULAV Asset Management’s Avanos Medical AVNS Stock Holding History

EULAV Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17,500
Closed -$590K – 256
2019
Q4 		$590K Hold
17,500
– – 0.02% 267
2019
Q3 		$656K Hold
17,500
– – 0.02% 278
2019
Q2 		$763K Sell
17,500
-2,800
-14% -$120K 0.03% 281
2019
Q1 		$876K Sell
20,300
-1,800
-8% -$80.6K 0.04% 263
2018
Q4 		$990K Hold
22,100
– – 0.05% 231
2018
Q3 		$1.51M Buy
+22,100
New +$1.42M 0.06% 213

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

EULAV Asset Management's AVNS Position: Q1 2020 in Review

EULAV Asset Management sold out of Avanos Medical (AVNS) in Q1 2020, closing a stake of 17,500 shares — an estimated $590K sold.

EULAV Asset Management first reported a position in AVNS in Q3 2018 and held it in 6 quarters. The position peaked at $1.51M in Q3 2018. 272 funds tracked by Wall St. Rank hold AVNS as of Q1 2020.

  • EULAV Asset Management reported no remaining Avanos Medical position as of Q1 2020 after selling out during the quarter.
  • EULAV Asset Management sold 17,500 Avanos Medical shares in Q1 2020, an estimated $590K.
  • EULAV Asset Management first reported a position in Avanos Medical in Q3 2018 and held it in 6 quarters.
  • EULAV Asset Management's Avanos Medical position peaked at $1.51M in Q3 2018.
  • 272 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2020.

Based on EULAV Asset Management's 13F filing for Q1 2020, filed 27 Apr 2020.